2015
DOI: 10.1016/j.intimp.2015.06.035
|View full text |Cite
|
Sign up to set email alerts
|

Decreased expression of IL-33 in immune thrombocytopenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
6
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 46 publications
2
6
0
Order By: Relevance
“…This agreed with (15) who aimed to measure the expression of IL-33 in active immune thrombocytopenia (ITP) compared to controlsThirty-two ITP patients measured in plasma using ELISA and compared with 27 age-and sex-matched healthy controls.IL-33 in the ITP patients with active disease were significantly lower than those of the healthy controls. Significantly lower IL-33 and higher sST2 plasma levels were found in the active ITP patients compared with the ITP patients in .However, no significant differences in the IL-33 and sST2 plasma levels were found between the ITP patients in remission and healthy controls.…”
Section: )supporting
confidence: 74%
See 3 more Smart Citations
“…This agreed with (15) who aimed to measure the expression of IL-33 in active immune thrombocytopenia (ITP) compared to controlsThirty-two ITP patients measured in plasma using ELISA and compared with 27 age-and sex-matched healthy controls.IL-33 in the ITP patients with active disease were significantly lower than those of the healthy controls. Significantly lower IL-33 and higher sST2 plasma levels were found in the active ITP patients compared with the ITP patients in .However, no significant differences in the IL-33 and sST2 plasma levels were found between the ITP patients in remission and healthy controls.…”
Section: )supporting
confidence: 74%
“…However, there was no significant difference between the patients in remission and normal controls. (15) CONCLUSION This study concluded that, IL-33 may contribute to the pathogenesis of ITP. It could be a potential biomarker that diagnose and…”
Section: )mentioning
confidence: 67%
See 2 more Smart Citations
“…It might play a pivotal role in the coagulopathy mechanism of DENV infections. One study [29] claimed that IL-33 expression decreased in patients with immune thrombocytopenia. IL-33 increases cell surface tissue factor, a major trigger of coagulation, and it significantly reduces the coagulation time of human whole blood and plasma samples [30].…”
Section: Discussionmentioning
confidence: 99%